Metformin Prescriptions Linked to Son’s Birth Defects

March 31, 2022

(The Scientist) – Men who took the type 2 diabetes drug metformin three months before conceiving their children seem to have an increased risk of having sons with birth defects, new research finds. The study, a retroactive analysis of Denmark’s federal registry of healthcare data that was published Tuesday (March 29) in Annals of Internal Medicine, found a significantly increased risk of genital birth defects among boys whose fathers had filled a prescription for metformin—commonly branded as Glucophage, Riomet, and Glumetza—about three months prior to conception, roughly the duration of time it takes for sperm to mature. A correlation between birth defects and paternal metformin prescriptions was not seen in girls, according to the study. (Read More)